2018-2023 Global Infantile Spasms Therapeutics Consumption Market Report
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Infantile Spasms Therapeutics market for 2018-2023.
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.
The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.
Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.
United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.
The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.
In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.
Over the next five years, LPI(LP Information) projects that Infantile Spasms Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Infantile Spasms Therapeutics market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Infantile Spasms Therapeutics market for 2018-2023.
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.
The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.
Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.
United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.
The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.
In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.
Over the next five years, LPI(LP Information) projects that Infantile Spasms Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Infantile Spasms Therapeutics market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
- Oral
- Injection
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mallinckrodt
- H. Lundbeck
- Insys Therapeutics
- Orphelia Pharma
- Valerion Therapeutics
- Catalyst Pharmaceuticals
- Anavex Life Sciences
- Retrophin
- GW Pharmaceuticals
Research objectives
- To study and analyze the global Infantile Spasms Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Infantile Spasms Therapeutics market by identifying its various subsegments.
- Focuses on the key global Infantile Spasms Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Infantile Spasms Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Infantile Spasms Therapeutics submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infantile Spasms Therapeutics Consumption 2013-2023
2.1.2 Infantile Spasms Therapeutics Consumption CAGR by Region
2.2 Infantile Spasms Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Injection
2.3 Infantile Spasms Therapeutics Consumption by Type
2.3.1 Global Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
2.3.2 Global Infantile Spasms Therapeutics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Infantile Spasms Therapeutics Sale Price by Type (2013-2018)
2.4 Infantile Spasms Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Infantile Spasms Therapeutics Consumption by Application
2.5.1 Global Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
2.5.2 Global Infantile Spasms Therapeutics Value and Market Share by Application (2013-2018)
2.5.3 Global Infantile Spasms Therapeutics Sale Price by Application (2013-2018)
3 GLOBAL INFANTILE SPASMS THERAPEUTICS BY PLAYERS
3.1 Global Infantile Spasms Therapeutics Sales Market Share by Players
3.1.1 Global Infantile Spasms Therapeutics Sales by Players (2016-2018)
3.1.2 Global Infantile Spasms Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players
3.2.1 Global Infantile Spasms Therapeutics Revenue by Players (2016-2018)
3.2.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Infantile Spasms Therapeutics Sale Price by Players
3.4 Global Infantile Spasms Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Infantile Spasms Therapeutics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Infantile Spasms Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 INFANTILE SPASMS THERAPEUTICS BY REGIONS
4.1 Infantile Spasms Therapeutics by Regions
4.1.1 Global Infantile Spasms Therapeutics Consumption by Regions
4.1.2 Global Infantile Spasms Therapeutics Value by Regions
4.2 Americas Infantile Spasms Therapeutics Consumption Growth
4.3 APAC Infantile Spasms Therapeutics Consumption Growth
4.4 Europe Infantile Spasms Therapeutics Consumption Growth
4.5 Middle East & Africa Infantile Spasms Therapeutics Consumption Growth
5 AMERICAS
5.1 Americas Infantile Spasms Therapeutics Consumption by Countries
5.1.1 Americas Infantile Spasms Therapeutics Consumption by Countries (2013-2018)
5.1.2 Americas Infantile Spasms Therapeutics Value by Countries (2013-2018)
5.2 Americas Infantile Spasms Therapeutics Consumption by Type
5.3 Americas Infantile Spasms Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Infantile Spasms Therapeutics Consumption by Countries
6.1.1 APAC Infantile Spasms Therapeutics Consumption by Countries (2013-2018)
6.1.2 APAC Infantile Spasms Therapeutics Value by Countries (2013-2018)
6.2 APAC Infantile Spasms Therapeutics Consumption by Type
6.3 APAC Infantile Spasms Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Infantile Spasms Therapeutics by Countries
7.1.1 Europe Infantile Spasms Therapeutics Consumption by Countries (2013-2018)
7.1.2 Europe Infantile Spasms Therapeutics Value by Countries (2013-2018)
7.2 Europe Infantile Spasms Therapeutics Consumption by Type
7.3 Europe Infantile Spasms Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infantile Spasms Therapeutics by Countries
8.1.1 Middle East & Africa Infantile Spasms Therapeutics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Infantile Spasms Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Infantile Spasms Therapeutics Consumption by Type
8.3 Middle East & Africa Infantile Spasms Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Infantile Spasms Therapeutics Distributors
10.3 Infantile Spasms Therapeutics Customer
11 GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET FORECAST
11.1 Global Infantile Spasms Therapeutics Consumption Forecast (2018-2023)
11.2 Global Infantile Spasms Therapeutics Forecast by Regions
11.2.1 Global Infantile Spasms Therapeutics Forecast by Regions (2018-2023)
11.2.2 Global Infantile Spasms Therapeutics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Infantile Spasms Therapeutics Forecast by Type
11.8 Global Infantile Spasms Therapeutics Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Mallinckrodt
12.1.1 Company Details
12.1.2 Infantile Spasms Therapeutics Product Offered
12.1.3 Mallinckrodt Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Mallinckrodt News
12.2 H. Lundbeck
12.2.1 Company Details
12.2.2 Infantile Spasms Therapeutics Product Offered
12.2.3 H. Lundbeck Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 H. Lundbeck News
12.3 Insys Therapeutics
12.3.1 Company Details
12.3.2 Infantile Spasms Therapeutics Product Offered
12.3.3 Insys Therapeutics Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Insys Therapeutics News
12.4 Orphelia Pharma
12.4.1 Company Details
12.4.2 Infantile Spasms Therapeutics Product Offered
12.4.3 Orphelia Pharma Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Orphelia Pharma News
12.5 Valerion Therapeutics
12.5.1 Company Details
12.5.2 Infantile Spasms Therapeutics Product Offered
12.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Valerion Therapeutics News
12.6 Catalyst Pharmaceuticals
12.6.1 Company Details
12.6.2 Infantile Spasms Therapeutics Product Offered
12.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Catalyst Pharmaceuticals News
12.7 Anavex Life Sciences
12.7.1 Company Details
12.7.2 Infantile Spasms Therapeutics Product Offered
12.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Anavex Life Sciences News
12.8 Retrophin
12.8.1 Company Details
12.8.2 Infantile Spasms Therapeutics Product Offered
12.8.3 Retrophin Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Retrophin News
12.9 GW Pharmaceuticals
12.9.1 Company Details
12.9.2 Infantile Spasms Therapeutics Product Offered
12.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 GW Pharmaceuticals News
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infantile Spasms Therapeutics Consumption 2013-2023
2.1.2 Infantile Spasms Therapeutics Consumption CAGR by Region
2.2 Infantile Spasms Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Injection
2.3 Infantile Spasms Therapeutics Consumption by Type
2.3.1 Global Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
2.3.2 Global Infantile Spasms Therapeutics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Infantile Spasms Therapeutics Sale Price by Type (2013-2018)
2.4 Infantile Spasms Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Infantile Spasms Therapeutics Consumption by Application
2.5.1 Global Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
2.5.2 Global Infantile Spasms Therapeutics Value and Market Share by Application (2013-2018)
2.5.3 Global Infantile Spasms Therapeutics Sale Price by Application (2013-2018)
3 GLOBAL INFANTILE SPASMS THERAPEUTICS BY PLAYERS
3.1 Global Infantile Spasms Therapeutics Sales Market Share by Players
3.1.1 Global Infantile Spasms Therapeutics Sales by Players (2016-2018)
3.1.2 Global Infantile Spasms Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players
3.2.1 Global Infantile Spasms Therapeutics Revenue by Players (2016-2018)
3.2.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Infantile Spasms Therapeutics Sale Price by Players
3.4 Global Infantile Spasms Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Infantile Spasms Therapeutics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Infantile Spasms Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 INFANTILE SPASMS THERAPEUTICS BY REGIONS
4.1 Infantile Spasms Therapeutics by Regions
4.1.1 Global Infantile Spasms Therapeutics Consumption by Regions
4.1.2 Global Infantile Spasms Therapeutics Value by Regions
4.2 Americas Infantile Spasms Therapeutics Consumption Growth
4.3 APAC Infantile Spasms Therapeutics Consumption Growth
4.4 Europe Infantile Spasms Therapeutics Consumption Growth
4.5 Middle East & Africa Infantile Spasms Therapeutics Consumption Growth
5 AMERICAS
5.1 Americas Infantile Spasms Therapeutics Consumption by Countries
5.1.1 Americas Infantile Spasms Therapeutics Consumption by Countries (2013-2018)
5.1.2 Americas Infantile Spasms Therapeutics Value by Countries (2013-2018)
5.2 Americas Infantile Spasms Therapeutics Consumption by Type
5.3 Americas Infantile Spasms Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Infantile Spasms Therapeutics Consumption by Countries
6.1.1 APAC Infantile Spasms Therapeutics Consumption by Countries (2013-2018)
6.1.2 APAC Infantile Spasms Therapeutics Value by Countries (2013-2018)
6.2 APAC Infantile Spasms Therapeutics Consumption by Type
6.3 APAC Infantile Spasms Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Infantile Spasms Therapeutics by Countries
7.1.1 Europe Infantile Spasms Therapeutics Consumption by Countries (2013-2018)
7.1.2 Europe Infantile Spasms Therapeutics Value by Countries (2013-2018)
7.2 Europe Infantile Spasms Therapeutics Consumption by Type
7.3 Europe Infantile Spasms Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infantile Spasms Therapeutics by Countries
8.1.1 Middle East & Africa Infantile Spasms Therapeutics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Infantile Spasms Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Infantile Spasms Therapeutics Consumption by Type
8.3 Middle East & Africa Infantile Spasms Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Infantile Spasms Therapeutics Distributors
10.3 Infantile Spasms Therapeutics Customer
11 GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET FORECAST
11.1 Global Infantile Spasms Therapeutics Consumption Forecast (2018-2023)
11.2 Global Infantile Spasms Therapeutics Forecast by Regions
11.2.1 Global Infantile Spasms Therapeutics Forecast by Regions (2018-2023)
11.2.2 Global Infantile Spasms Therapeutics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Infantile Spasms Therapeutics Forecast by Type
11.8 Global Infantile Spasms Therapeutics Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Mallinckrodt
12.1.1 Company Details
12.1.2 Infantile Spasms Therapeutics Product Offered
12.1.3 Mallinckrodt Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Mallinckrodt News
12.2 H. Lundbeck
12.2.1 Company Details
12.2.2 Infantile Spasms Therapeutics Product Offered
12.2.3 H. Lundbeck Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 H. Lundbeck News
12.3 Insys Therapeutics
12.3.1 Company Details
12.3.2 Infantile Spasms Therapeutics Product Offered
12.3.3 Insys Therapeutics Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Insys Therapeutics News
12.4 Orphelia Pharma
12.4.1 Company Details
12.4.2 Infantile Spasms Therapeutics Product Offered
12.4.3 Orphelia Pharma Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Orphelia Pharma News
12.5 Valerion Therapeutics
12.5.1 Company Details
12.5.2 Infantile Spasms Therapeutics Product Offered
12.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Valerion Therapeutics News
12.6 Catalyst Pharmaceuticals
12.6.1 Company Details
12.6.2 Infantile Spasms Therapeutics Product Offered
12.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Catalyst Pharmaceuticals News
12.7 Anavex Life Sciences
12.7.1 Company Details
12.7.2 Infantile Spasms Therapeutics Product Offered
12.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Anavex Life Sciences News
12.8 Retrophin
12.8.1 Company Details
12.8.2 Infantile Spasms Therapeutics Product Offered
12.8.3 Retrophin Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Retrophin News
12.9 GW Pharmaceuticals
12.9.1 Company Details
12.9.2 Infantile Spasms Therapeutics Product Offered
12.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 GW Pharmaceuticals News
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Infantile Spasms Therapeutics
Table Product Specifications of Infantile Spasms Therapeutics
Figure Infantile Spasms Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Infantile Spasms Therapeutics Consumption Growth Rate 2013-2023 (Units)
Figure Global Infantile Spasms Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Infantile Spasms Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Oral
Table Major Players of Oral
Figure Product Picture of Injection
Table Major Players of Injection
Table Global Consumption Sales by Type (2013-2018)
Table Global Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Infantile Spasms Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Infantile Spasms Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Infantile Spasms Therapeutics Value Market Share by Type (2013-2018)
Table Global Infantile Spasms Therapeutics Sale Price by Type (2013-2018)
Figure Infantile Spasms Therapeutics Consumed in Hospital
Figure Global Infantile Spasms Therapeutics Market: Hospital (2013-2018) (Units)
Figure Global Infantile Spasms Therapeutics Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Infantile Spasms Therapeutics Consumed in Clinic
Figure Global Infantile Spasms Therapeutics Market: Clinic (2013-2018) (Units)
Figure Global Infantile Spasms Therapeutics Market: Clinic (2013-2018) ($ Millions)
Figure Global Clinic YoY Growth ($ Millions)
Figure Infantile Spasms Therapeutics Consumed in Other
Figure Global Infantile Spasms Therapeutics Market: Other (2013-2018) (Units)
Figure Global Infantile Spasms Therapeutics Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Infantile Spasms Therapeutics Value by Application (2013-2018)
Table Global Infantile Spasms Therapeutics Value Market Share by Application (2013-2018)
Figure Global Infantile Spasms Therapeutics Value Market Share by Application (2013-2018)
Table Global Infantile Spasms Therapeutics Sale Price by Application (2013-2018)
Table Global Infantile Spasms Therapeutics Sales by Players (2016-2018) (Units)
Table Global Infantile Spasms Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Infantile Spasms Therapeutics Sales Market Share by Players in 2016
Figure Global Infantile Spasms Therapeutics Sales Market Share by Players in 2017
Table Global Infantile Spasms Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Infantile Spasms Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Infantile Spasms Therapeutics Revenue Market Share by Players in 2016
Figure Global Infantile Spasms Therapeutics Revenue Market Share by Players in 2017
Table Global Infantile Spasms Therapeutics Sale Price by Players (2016-2018)
Figure Global Infantile Spasms Therapeutics Sale Price by Players in 2017
Table Global Infantile Spasms Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Infantile Spasms Therapeutics Products Offered
Table Infantile Spasms Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Infantile Spasms Therapeutics Consumption by Regions 2013-2018 (Units)
Table Global Infantile Spasms Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Infantile Spasms Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Infantile Spasms Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Infantile Spasms Therapeutics Value Market Share by Regions 2013-2018
Figure Global Infantile Spasms Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Infantile Spasms Therapeutics Consumption 2013-2018 (Units)
Figure Americas Infantile Spasms Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Infantile Spasms Therapeutics Consumption 2013-2018 (Units)
Figure APAC Infantile Spasms Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Infantile Spasms Therapeutics Consumption 2013-2018 (Units)
Figure Europe Infantile Spasms Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Infantile Spasms Therapeutics Consumption 2013-2018 (Units)
Figure Middle East & Africa Infantile Spasms Therapeutics Value 2013-2018 ($ Millions)
Table Americas Infantile Spasms Therapeutics Consumption by Countries (2013-2018) (Units)
Table Americas Infantile Spasms Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Infantile Spasms Therapeutics Consumption Market Share by Countries in 2017
Table Americas Infantile Spasms Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Infantile Spasms Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Infantile Spasms Therapeutics Value Market Share by Countries in 2017
Table Americas Infantile Spasms Therapeutics Consumption by Type (2013-2018) (Units)
Table Americas Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Infantile Spasms Therapeutics Consumption Market Share by Type in 2017
Table Americas Infantile Spasms Therapeutics Consumption by Application (2013-2018) (Units)
Table Americas Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Infantile Spasms Therapeutics Consumption Market Share by Application in 2017
Figure United States Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure United States Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Canada Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Mexico Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Infantile Spasms Therapeutics Consumption by Countries (2013-2018) (Units)
Table APAC Infantile Spasms Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Infantile Spasms Therapeutics Consumption Market Share by Countries in 2017
Table APAC Infantile Spasms Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Infantile Spasms Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Infantile Spasms Therapeutics Value Market Share by Countries in 2017
Table APAC Infantile Spasms Therapeutics Consumption by Type (2013-2018) (Units)
Table APAC Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Infantile Spasms Therapeutics Consumption Market Share by Type in 2017
Table APAC Infantile Spasms Therapeutics Consumption by Application (2013-2018) (Units)
Table APAC Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Infantile Spasms Therapeutics Consumption Market Share by Application in 2017
Figure China Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure China Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Japan Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Korea Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Southeast Asia Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure India Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Australia Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Infantile Spasms Therapeutics Consumption by Countries (2013-2018) (Units)
Table Europe Infantile Spasms Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Infantile Spasms Therapeutics Consumption Market Share by Countries in 2017
Table Europe Infantile Spasms Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Infantile Spasms Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Infantile Spasms Therapeutics Value Market Share by Countries in 2017
Table Europe Infantile Spasms Therapeutics Consumption by Type (2013-2018) (Units)
Table Europe Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Infantile Spasms Therapeutics Consumption Market Share by Type in 2017
Table Europe Infantile Spasms Therapeutics Consumption by Application (2013-2018) (Units)
Table Europe Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Infantile Spasms Therapeutics Consumption Market Share by Application in 2017
Figure Germany Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Germany Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure France Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure UK Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Italy Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Russia Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Spain Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Infantile Spasms Therapeutics Consumption by Countries (2013-2018) (Units)
Table Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Infantile Spasms Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Infantile Spasms Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Infantile Spasms Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Infantile Spasms Therapeutics Consumption by Type (2013-2018) (Units)
Table Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Infantile Spasms Therapeutics Consumption by Application (2013-2018) (Units)
Table Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Egypt Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure South Africa Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Israel Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Turkey Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure GCC Countries Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Table Infantile Spasms Therapeutics Distributors List
Table Infantile Spasms Therapeutics Customer List
Figure Global Infantile Spasms Therapeutics Consumption Growth Rate Forecast (2018-2023) (Units)
Figure Global Infantile Spasms Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Infantile Spasms Therapeutics Consumption Forecast by Countries (2018-2023) (Units)
Table Global Infantile Spasms Therapeutics Consumption Market Forecast by Regions
Table Global Infantile Spasms Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Infantile Spasms Therapeutics Value Market Share Forecast by Regions
Figure Americas Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Americas Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure APAC Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Europe Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Middle East & Africa Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure United States Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure United States Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Canada Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Mexico Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Brazil Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure China Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure China Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Japan Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Korea Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Southeast Asia Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure India Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure India Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Australia Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Germany Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure France Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure France Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure UK Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure UK Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Italy Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Russia Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Spain Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Egypt Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure South Africa Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Israel Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Turkey Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure GCC Countries Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Table Global Infantile Spasms Therapeutics Consumption Forecast by Type (2018-2023) (Units)
Table Global Infantile Spasms Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Infantile Spasms Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Infantile Spasms Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Infantile Spasms Therapeutics Consumption Forecast by Application (2018-2023) (Units)
Table Global Infantile Spasms Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Infantile Spasms Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Infantile Spasms Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Mallinckrodt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mallinckrodt Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mallinckrodt Infantile Spasms Therapeutics Market Share (2016-2018)
Table H. Lundbeck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table H. Lundbeck Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure H. Lundbeck Infantile Spasms Therapeutics Market Share (2016-2018)
Table Insys Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Insys Therapeutics Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Insys Therapeutics Infantile Spasms Therapeutics Market Share (2016-2018)
Table Orphelia Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Orphelia Pharma Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Orphelia Pharma Infantile Spasms Therapeutics Market Share (2016-2018)
Table Valerion Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valerion Therapeutics Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Valerion Therapeutics Infantile Spasms Therapeutics Market Share (2016-2018)
Table Catalyst Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Catalyst Pharmaceuticals Infantile Spasms Therapeutics Market Share (2016-2018)
Table Anavex Life Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Anavex Life Sciences Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Anavex Life Sciences Infantile Spasms Therapeutics Market Share (2016-2018)
Table Retrophin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Retrophin Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Retrophin Infantile Spasms Therapeutics Market Share (2016-2018)
Table GW Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GW Pharmaceuticals Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GW Pharmaceuticals Infantile Spasms Therapeutics Market Share (2016-2018)
Figure Picture of Infantile Spasms Therapeutics
Table Product Specifications of Infantile Spasms Therapeutics
Figure Infantile Spasms Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Infantile Spasms Therapeutics Consumption Growth Rate 2013-2023 (Units)
Figure Global Infantile Spasms Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Infantile Spasms Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Oral
Table Major Players of Oral
Figure Product Picture of Injection
Table Major Players of Injection
Table Global Consumption Sales by Type (2013-2018)
Table Global Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Infantile Spasms Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Infantile Spasms Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Infantile Spasms Therapeutics Value Market Share by Type (2013-2018)
Table Global Infantile Spasms Therapeutics Sale Price by Type (2013-2018)
Figure Infantile Spasms Therapeutics Consumed in Hospital
Figure Global Infantile Spasms Therapeutics Market: Hospital (2013-2018) (Units)
Figure Global Infantile Spasms Therapeutics Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Infantile Spasms Therapeutics Consumed in Clinic
Figure Global Infantile Spasms Therapeutics Market: Clinic (2013-2018) (Units)
Figure Global Infantile Spasms Therapeutics Market: Clinic (2013-2018) ($ Millions)
Figure Global Clinic YoY Growth ($ Millions)
Figure Infantile Spasms Therapeutics Consumed in Other
Figure Global Infantile Spasms Therapeutics Market: Other (2013-2018) (Units)
Figure Global Infantile Spasms Therapeutics Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Infantile Spasms Therapeutics Value by Application (2013-2018)
Table Global Infantile Spasms Therapeutics Value Market Share by Application (2013-2018)
Figure Global Infantile Spasms Therapeutics Value Market Share by Application (2013-2018)
Table Global Infantile Spasms Therapeutics Sale Price by Application (2013-2018)
Table Global Infantile Spasms Therapeutics Sales by Players (2016-2018) (Units)
Table Global Infantile Spasms Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Infantile Spasms Therapeutics Sales Market Share by Players in 2016
Figure Global Infantile Spasms Therapeutics Sales Market Share by Players in 2017
Table Global Infantile Spasms Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Infantile Spasms Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Infantile Spasms Therapeutics Revenue Market Share by Players in 2016
Figure Global Infantile Spasms Therapeutics Revenue Market Share by Players in 2017
Table Global Infantile Spasms Therapeutics Sale Price by Players (2016-2018)
Figure Global Infantile Spasms Therapeutics Sale Price by Players in 2017
Table Global Infantile Spasms Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Infantile Spasms Therapeutics Products Offered
Table Infantile Spasms Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Infantile Spasms Therapeutics Consumption by Regions 2013-2018 (Units)
Table Global Infantile Spasms Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Infantile Spasms Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Infantile Spasms Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Infantile Spasms Therapeutics Value Market Share by Regions 2013-2018
Figure Global Infantile Spasms Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Infantile Spasms Therapeutics Consumption 2013-2018 (Units)
Figure Americas Infantile Spasms Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Infantile Spasms Therapeutics Consumption 2013-2018 (Units)
Figure APAC Infantile Spasms Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Infantile Spasms Therapeutics Consumption 2013-2018 (Units)
Figure Europe Infantile Spasms Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Infantile Spasms Therapeutics Consumption 2013-2018 (Units)
Figure Middle East & Africa Infantile Spasms Therapeutics Value 2013-2018 ($ Millions)
Table Americas Infantile Spasms Therapeutics Consumption by Countries (2013-2018) (Units)
Table Americas Infantile Spasms Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Infantile Spasms Therapeutics Consumption Market Share by Countries in 2017
Table Americas Infantile Spasms Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Infantile Spasms Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Infantile Spasms Therapeutics Value Market Share by Countries in 2017
Table Americas Infantile Spasms Therapeutics Consumption by Type (2013-2018) (Units)
Table Americas Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Infantile Spasms Therapeutics Consumption Market Share by Type in 2017
Table Americas Infantile Spasms Therapeutics Consumption by Application (2013-2018) (Units)
Table Americas Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Infantile Spasms Therapeutics Consumption Market Share by Application in 2017
Figure United States Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure United States Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Canada Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Mexico Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Infantile Spasms Therapeutics Consumption by Countries (2013-2018) (Units)
Table APAC Infantile Spasms Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Infantile Spasms Therapeutics Consumption Market Share by Countries in 2017
Table APAC Infantile Spasms Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Infantile Spasms Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Infantile Spasms Therapeutics Value Market Share by Countries in 2017
Table APAC Infantile Spasms Therapeutics Consumption by Type (2013-2018) (Units)
Table APAC Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Infantile Spasms Therapeutics Consumption Market Share by Type in 2017
Table APAC Infantile Spasms Therapeutics Consumption by Application (2013-2018) (Units)
Table APAC Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Infantile Spasms Therapeutics Consumption Market Share by Application in 2017
Figure China Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure China Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Japan Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Korea Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Southeast Asia Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure India Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Australia Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Infantile Spasms Therapeutics Consumption by Countries (2013-2018) (Units)
Table Europe Infantile Spasms Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Infantile Spasms Therapeutics Consumption Market Share by Countries in 2017
Table Europe Infantile Spasms Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Infantile Spasms Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Infantile Spasms Therapeutics Value Market Share by Countries in 2017
Table Europe Infantile Spasms Therapeutics Consumption by Type (2013-2018) (Units)
Table Europe Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Infantile Spasms Therapeutics Consumption Market Share by Type in 2017
Table Europe Infantile Spasms Therapeutics Consumption by Application (2013-2018) (Units)
Table Europe Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Infantile Spasms Therapeutics Consumption Market Share by Application in 2017
Figure Germany Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Germany Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure France Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure UK Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Italy Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Russia Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Spain Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Infantile Spasms Therapeutics Consumption by Countries (2013-2018) (Units)
Table Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Infantile Spasms Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Infantile Spasms Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Infantile Spasms Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Infantile Spasms Therapeutics Consumption by Type (2013-2018) (Units)
Table Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Infantile Spasms Therapeutics Consumption by Application (2013-2018) (Units)
Table Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Infantile Spasms Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Egypt Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure South Africa Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Israel Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure Turkey Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Infantile Spasms Therapeutics Consumption Growth 2013-2018 (Units)
Figure GCC Countries Infantile Spasms Therapeutics Value Growth 2013-2018 ($ Millions)
Table Infantile Spasms Therapeutics Distributors List
Table Infantile Spasms Therapeutics Customer List
Figure Global Infantile Spasms Therapeutics Consumption Growth Rate Forecast (2018-2023) (Units)
Figure Global Infantile Spasms Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Infantile Spasms Therapeutics Consumption Forecast by Countries (2018-2023) (Units)
Table Global Infantile Spasms Therapeutics Consumption Market Forecast by Regions
Table Global Infantile Spasms Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Infantile Spasms Therapeutics Value Market Share Forecast by Regions
Figure Americas Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Americas Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure APAC Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Europe Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Middle East & Africa Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure United States Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure United States Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Canada Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Mexico Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Brazil Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure China Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure China Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Japan Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Korea Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Southeast Asia Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure India Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure India Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Australia Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Germany Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure France Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure France Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure UK Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure UK Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Italy Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Russia Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Spain Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Egypt Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure South Africa Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Israel Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure Turkey Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Infantile Spasms Therapeutics Consumption 2018-2023 (Units)
Figure GCC Countries Infantile Spasms Therapeutics Value 2018-2023 ($ Millions)
Table Global Infantile Spasms Therapeutics Consumption Forecast by Type (2018-2023) (Units)
Table Global Infantile Spasms Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Infantile Spasms Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Infantile Spasms Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Infantile Spasms Therapeutics Consumption Forecast by Application (2018-2023) (Units)
Table Global Infantile Spasms Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Infantile Spasms Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Infantile Spasms Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Mallinckrodt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mallinckrodt Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mallinckrodt Infantile Spasms Therapeutics Market Share (2016-2018)
Table H. Lundbeck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table H. Lundbeck Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure H. Lundbeck Infantile Spasms Therapeutics Market Share (2016-2018)
Table Insys Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Insys Therapeutics Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Insys Therapeutics Infantile Spasms Therapeutics Market Share (2016-2018)
Table Orphelia Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Orphelia Pharma Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Orphelia Pharma Infantile Spasms Therapeutics Market Share (2016-2018)
Table Valerion Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valerion Therapeutics Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Valerion Therapeutics Infantile Spasms Therapeutics Market Share (2016-2018)
Table Catalyst Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Catalyst Pharmaceuticals Infantile Spasms Therapeutics Market Share (2016-2018)
Table Anavex Life Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Anavex Life Sciences Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Anavex Life Sciences Infantile Spasms Therapeutics Market Share (2016-2018)
Table Retrophin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Retrophin Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Retrophin Infantile Spasms Therapeutics Market Share (2016-2018)
Table GW Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GW Pharmaceuticals Infantile Spasms Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GW Pharmaceuticals Infantile Spasms Therapeutics Market Share (2016-2018)
